Agentic AI is not just generating text. It can take action inside healthcare systems, and that changes the risk right now.
If I had to sum up the article in plain English, it’s this:
- Agentic AI can read, decide, and act across EHRs, billing tools, schedulers, and external services.
- That means the risk is no longer limited to bad answers. It also includes bad actions, too much PHI access, machine identity abuse, and third-party data exposure.
- In healthcare, that matters fast because systems are already connected through APIs.
- The article points to a hard backdrop: healthcare ransomware attacks were up 30% in 2025, and 379 large breaches in the first half of 2025 affected more than 31 million people.
- HIPAA and HITECH still apply. If an agent touches PHI, teams still need minimum necessary access, logging, encryption, review steps, and breach response.
What should you do now?
- Inventory every agentic AI use case
- Assign a business owner and technical owner
- Limit each agent’s access and tool permissions
- Require human approval for high-risk actions
- Monitor prompts, tool calls, writes, and external API traffic
- Review vendors, BAAs, subcontractors, retention, and PHI flow
Here’s the main point: treat agentic AI as a separate healthcare risk category. If I wait until these systems are tied into clinical or revenue workflows, cleanup gets much harder.
A short way to think about it: assistive AI suggests; agentic AI does. And once AI starts doing, security controls have to change too.
Agentic AI Healthcare Security Risks: Key Stats & Action Steps
Zero Trust in the Agentic Age: Securing Agentic AI with ChristianaCare CISO | Webinar (5 of 6)
The main risks healthcare security teams should assess now
The biggest risks fall into three buckets: PHI over-access, identity misuse, and third-party exposure.
PHI over-access and minimum necessary violations
An agent that’s only supposed to draft one discharge summary can end up pulling records for an entire patient panel. The task needed one chart. But because the agent works on its own, without step-by-step human input, it can scan thousands of records at machine speed before anyone spots the problem. That’s a minimum necessary violation happening far faster than any manual review could stop.[1][2][7][8]
It gets messier when the logs become part of the problem. Many agent frameworks store full prompts, intermediate tool outputs, and system messages. In plain English, that can put diagnoses, medication lists, and patient identifiers into logs or tools that sit outside normal encryption, retention, and access controls. For HIPAA, that opens a gap around transmission security and data at rest.[1][4][7]
There’s also the handoff issue. An agent that can read from an EHR and write to a task tracker, CRM, or productivity suite can move PHI across system boundaries with little friction. If those moves happen without the right guardrails, access control and auditability can fall apart fast.[3][4][7]
Identity misuse, unsafe automation, and cross-system actions
A lot of agentic AI setups run under a user’s credentials or a shared service account. That sounds simple on paper, but it creates a basic problem: if several agents share one identity, who actually made the change? Once that answer gets fuzzy, forensic work and compliance reporting get shaky too.[5][8]
The secret-management side is just as risky. API keys and OAuth tokens are still too often stored in plain-text config files, hard-coded in scripts, or reused across environments. If one setup gets exposed, an attacker may get broad access and move from EHRs to schedulers to billing tools. Research on non-human identities found that about 80% of identity breaches involved service accounts, API keys, and similar machine identities.[16]
Agentic AI makes this worse because agents often reuse long-lived secrets across many tools, and they do it at machine speed. If a key leaks through prompt injection or a stray config file, an attacker can chain actions across every system that agent can touch.[14][15]
Then there’s unsafe automation. An agent with scheduling access could reschedule a large batch of appointments based on bad logic. An agent that edits encounter notes could insert wrong information that then flows into billing, coding, and clinical decision support.[4][6][8] One bad action doesn’t always stay contained, either. Research on agentic systems found that unsafe behavior can spread from one agent to another, so a corrupted data source or a malicious prompt can trigger harmful workflow changes across connected systems.[13]
That’s the heart of the issue: write access without mandatory human review checkpoints can turn a small mistake into a system-wide problem.
Third-party exposure and compliance gaps
Every external API call can widen the blast radius. A clinical documentation agent might call a large language model API from one vendor, hosted by a third provider, while also connecting to a scheduling tool from a fourth. If prompts or payloads contain PHI, each of those entities may qualify as a business associate or subcontractor under HIPAA.[7][9]
So this isn’t just a security issue. It’s also a contract and compliance issue.
The numbers make that plain. In 2024, about 35% of healthcare breaches started with third-party service or software providers, and about 30% to 39.5% of large breaches occurred at business associates.[10][11][12] Agentic AI adds more layers to that exposure because the data path is harder to trace, and the paperwork often hasn’t caught up.
Some of the most common gaps show up in BAAs that don’t deal with AI-specific issues, such as:
- model training on PHI
- data retention in training data or model weights
- subcontractor flow-down provisions[5][9]
The compliance gap that matters most right now is undocumented autonomous action: what agents are allowed to do without human approval, how those actions are logged, and how the organization can show control to auditors or OCR if something goes wrong.[2][9]
Controls that reduce agentic AI risk in healthcare
The controls below line up with the three risks discussed above: PHI access, identity misuse, and third-party exposure. Agentic AI only becomes manageable when healthcare teams control who owns it, what it can access, and what it can do in production.
Build AI governance with clear human approval points
The main gap for many healthcare organizations right now is implementation, not awareness. A lot of AI committees exist on paper, but their decisions still haven't turned into day-to-day controls and policies for governing autonomous agents.
Each agent should have:
- a business owner
- a technical owner
- a live inventory entry that documents its purpose, access, PHI reach, and BAA status [18][19][23]
Those owners are responsible for keeping the agent inside its approved scope and limiting access to approved data [19][27].
Human-in-the-loop checkpoints are not optional for high-stakes work. Require approval from a licensed clinician or other qualified reviewer before an agent affects diagnosis, medication, patient messaging, or high-impact scheduling [17][18][23]. The reviewer needs to see the evidence, override the recommendation if needed, and log the decision. A rubber-stamp workflow does not count.
Governance works only when ownership, approval, and inventory are enforced in daily operations.
Limit access, tool scope, and data transfer by design
Give each agent its own workload identity with tightly scoped permissions [19][21][25]. Use RBAC for people, and use workload identity plus ABAC for agents, tied to the patient relationship, episode of care, department, and task [19][26]. In plain terms, a chart summarization agent should only see records tied to the current encounter, not the patient’s full panel.
Use TLS 1.3 for data in transit, and encrypt agent logs, intermediate outputs, and vector stores at rest [23][24]. Apply PHI redaction or de-identification before data reaches external AI services whenever the use case allows it. Keep outbound connections on a strict allowlist. Agents should not be free to make random calls to the public internet [19][20][22]. Route clinical AI traffic through a governed gateway.
Test and monitor agent behavior at runtime
Access controls set limits on what agents can do. Runtime monitoring shows whether they actually stay inside those limits.
Monitoring needs to show what agents do, not just what they are allowed to do. Treat every prompt, tool call, retrieval action, and output as an auditable event [19][20][23]. Log the agent identity, data accessed, tools used, external calls, and human approval. Keep those logs for six years [28].
Use baselines for expected tool usage by agent so teams can spot anomalies - for example, an unusual volume of chart reads, access to systems outside the approved scope, or write operations that were never expected [20][26]. Those violations should trigger alerts and incident workflows, along with a documented process for restricting or revoking the agent’s access when needed.
When an agent starts to drift, monitoring should help teams contain it before the problem spreads across clinical or operational systems.
sbb-itb-535baee
How healthcare organizations can strengthen third-party AI oversight with Censinet
Vendor visibility is the missing piece. Without it, governance, access limits, and monitoring can still leave holes. That’s why third-party AI review needs to sit inside the same risk program as internal agent controls.
Use Censinet RiskOps to assess AI-related vendor and enterprise risk
Censinet RiskOps™ gives healthcare security teams one place to run structured assessments for AI-enabled vendors and internal use cases. Teams can use healthcare-specific questionnaires to review PHI flow, identity and access, logging, monitoring, and model governance.
A single dashboard shows risk scores, open issues, and residual risk. Benchmarking features let teams compare a vendor’s controls with peer organizations, industry norms, and frameworks. The platform also supports cross-functional sign-off before go-live.
Once teams can see vendor risk clearly, the next slowdown is obvious: reviewing the evidence fast enough to keep up.
Use Censinet AI to speed up AI vendor reviews
Censinet AI™ drafts questionnaire responses from vendor artifacts and summarizes key controls for reviewer validation. That shifts reviewer time toward gaps and inconsistencies instead of manual document review.
It also flags underlying cloud providers or logging services that can affect PHI exposure and incident response. In plain terms, it helps teams spot hidden dependencies before they turn into problems.
Use Censinet AI to support governed automation and oversight
Censinet AI can take on prep work while human analysts make the final call. For example, it can check vendor claims against attached artifacts - such as confirming that an encryption claim matches what’s shown in a security architecture diagram - and draft validation results for a security engineer to review and approve.
It can also draft acceptable-use policies, human-in-the-loop checkpoints, and mitigation plans. From there, findings can be routed to security, privacy, compliance, and clinical owners for approval. That creates a documented trail of decisions that regulators and accrediting bodies can audit.
Conclusion: Treat agentic AI as a healthcare risk category and prepare now
Agentic AI is already operating inside healthcare settings. And that autonomy makes it a separate security risk in healthcare.
The threat isn't hypothetical. It's here now. Agentic systems can access PHI, misuse credentials, and take action across connected systems faster than manual controls can respond. That's why agentic AI needs to be treated as an operational control problem, not just a policy issue.
There's also a clear readiness gap. Many organizations have set up AI governance committees, but they still haven't turned that awareness into day-to-day control. The issue isn't awareness. The issue is operational control.
A good place to start is inventory. Then move to ownership, access, and approval rules.
Inventory every agentic AI use case. Document which agents already exist or are planned, what systems and data they can touch, which vendors supply or host them, and what governance or approval steps are in place. That inventory becomes the base for your risk register, vendor due diligence process, and access control decisions.
Teams that inventory, govern, and monitor agentic AI now will be in a stronger position to protect patients, PHI, and operations.
FAQs
What makes agentic AI different from assistive AI?
Agentic AI is different from assistive AI because it can take action on its own, not just help a person do a task.
Assistive tools usually analyze data, answer questions, or surface information. Agentic systems go further. They can autonomously access Protected Health Information, trigger workflows, interact with vendors, and change operational or clinical settings.
That shift matters. Once a system can act without waiting for a person at each step, it introduces a new class of risk. And that means it needs tighter governance and closer oversight than more common AI tools.
How can healthcare teams find agentic AI already in use?
Move beyond one-time procurement checks and shift to continuous, enterprise-wide discovery. Keep a central AI inventory and model registry for every tool that touches PHI or supports clinical workflows.
Some tools can slip in without central sign-off. That’s why departments should document intended use, data access, and ownership before launch. On top of that, monitor network and identity signals for red flags like automated workflows, unusual API traffic, or unauthorized EHR interactions.
Which agentic AI actions should require human approval?
In healthcare, any agentic AI action that could affect patient care, clinical outcomes, or the integrity of the medical record should require human approval.
That includes outputs that shape clinical decisions, like sepsis alerts or triage recommendations. It also includes any AI-generated documentation or notes before someone signs off on them or adds them to the permanent medical record.
Organizations should also set clear review points anywhere an error could lead to serious patient harm or safety risks.
